ABSTRACT. Dyszoospermia due to genetic factors is the leading cause of male infertility. To explore the correlation between azoospermia factor (AZF) microdeletion of the Y chromosome and male infertility, we evaluated AZF microdeletion on the long arm of the Y chromosome in 166 infertile males and 50 fertile males using multiplex polymerase chain reactions amplification and gel electrophoresis. The results demonstrated that 28 individuals had varying degrees of microdeletion in the AZF region (16.90%); 12 out of the 76 males with azoospermia and 16 out of the 90 males with oligospermia had AZF microdeletion. AZF microdeletion was not observed in any of the healthy controls. In addition, 53.60% of the AZF microdeletions occurred in the AZFc region. It can be concluded that AZF microdeletion on the long arm of the Y chromosome can result in male spermatogenesis dysfunction. Detection of AZF microdeletion can provide a theoretical basis for genetic counseling, as well as improve the diagnosis and treatment of this disease.
INTRODUCTION
Infertility affects 10 to 15% of childbearing couples, and male infertility accounts for 50% of these cases. Y chromosome microdeletion is a major pathogenic factor that leads to male sterility (Hucklenbroich et al., 2005; Patrat et al., 2010) . Microdeletions can result in varying degrees of dyszoospermia, which ranges from azoospermia to severe oligospermia (Zhu et al., 2007; Martin, 2008) . Studies have found that approximately 60% of Y chromosome microdeletions occur in the AZFc region (Rodovalho et al., 2008; Dai et al., 2015) . AZFc deletion can generate diverse clinical phenotypes. It has been shown that two-thirds of infertile males develop azoospermia, of which 50% of the patients can regain fertility following testicular biopsy; the remaining one-third have oligospermia.
In 1976, Tiepolo and Zuffardi (1976) hypothesized that a gene that could control spermatogenesis is located at the distal end of the long arm of the Y chromosome. This gene was named as azoospermia factor (AZF). Y chromosome AZF can be further divided into AZFa, AZFb, AZFc, and AZFd; microdeletion at any of these sites can lead to dyszoospermia; when Y chromosome microdeletion occurs in any of these four regions, it is referred to as AZF microdeletion (Medica et al., 2005) . The incidence of AZFc microdeletion is high, and can lead to diverse clinical outcomes that alter the total count or the structure of sperms. The topic of Y chromosome microdeletions has become a hotspot in scientific research, and is also a challenging field of study both in China and abroad Chen et al., 2010) .
Recently, modern molecular biology and cell genetics studies have also confirmed the existence of AZF in the q11 region on the long arm of the Y chromosome (Kleiman et al., 2001) . A study (Kleiman et al, 2002) suggested that, 50% of patients with AZFc deletions could recover fertilization following testis puncture and intracytoplasmic sperm injection (ICSI). Liu et al. (2013) suggested that AZFc deletion is more likely to be passed onto male offsprings, but would not increase the risks of infertility among female offsprings. Patients can choose to undergo preimplantation genetic diagnosis followed by sperm implantation in female embryos. Detection of Y chromosome microdeletion can help determine the causes of infertility in males with non-obstructive azoospermia and moderate-to-severe oligospermia. Furthermore, it can also assist patients in choosing the appropriate assisted reproductive therapy, which is of great significance for the diagnosis and treatment of male infertility. This study selected 166 males with sperm abnormality who received treatments in the First Affiliated Hospital of Zhengzhou University and 50 healthy patients who have undergone Y chromosome AZF microdeletion detection.
MATERIAL AND METHODS

Clinical data
We retrospectively analyzed 166 infertile males who were diagnosed and treated at the Andrology Clinic of the Reproductive Center at the First Affiliated Hospital of Zhengzhou University, Henan, China, from February 2010 to February 2014. The patients included had been married for 2 to 13 years, and their wives all had normal reproductive capacity; the patients and their wives had lived together for more than 2 years. Fertilization had not occurred in these cases when no contraception measures were adopted. After strict screening and exclusion of other reasons such as infection, seminal fluid collected from the patients was analyzed. According to the seminal fluid analysis criteria of WHO (Mitra et al., 2006) , patients whose seminal fluid was found to have no sperm thrice on testing were diagnosed as having azoospermia; those whose sperm concentration was lower than 5 x 10 6 /mL were diagnosed as having severe oligospermia. Patients whose seminal fluid showed abnormalities underwent Y chromosome AZF microdeletion detection. Healthy women were used as negative controls and 50 married men whose seminal fluid concentration was higher than 20 x 10 6 /mL were used as healthy controls. All research subjects signed the informed consent form. This study follows the ethical principles of assisted reproductive technology of the Ministry of Health and has been approved by the ethics committee of reproductive medicine of the First Affiliated Hospital of Zhengzhou University.
Research methods
DNA extraction
Venous blood (2 mL) was drawn from the patient and collected into an anticoagulation tube. DNA was extracted using the phenyl-chloroform method. The concentration and purity of DNA were detected. DNA concentration was then adjusted to 80-150 ng/µL, and was stored at -20°C. Patients whose chromosome number was abnormal were not required to undergo AZF gene detection.
Multiplex polymerase chain reaction (PCR)
The following 15 sequence tag sites (STS) were detected using the Y chromosome microdeletion detection kit provided by Shenzhen Yaneng Biotech: SY82, SY84, and SY86 from the AZFa region; SY124, SY127, SY143, SY134, SY128, and SY133 from the AZFb region; SY254, SY255, SY242, and SY239 from the AZFc region; and SY152 and SY145 from the AZFd region. The 15 STSs were amplified in four tubes with the following colors: purple, white, blue, and yellow. The detailed matching of sample and tubes is detailed in Table  1 . Each reaction mixture was composed of 14 µL PCR solution, 10 µL deionized water, and 1 µL DNA. The amplification protocol are as follows: pre-degeneration at 95°C for 15 min; degeneration at 95°C for 30 s, annealing at 57°C for 60 s, extension at 72°C for 60 s for 35 cycles; extension at 72°C for 10 min; heat preservation at 4°C. The sex-determining region on the Y-chromosome SRY gene was used as the internal control. In every test, DNA extracted from married males was taken as the positive control and DNA from healthy females was taken as the negative control.
Detection of amplification product with gel electrophoresis
PCR products (10 µL) were run on 2% Sepharose gels containing ethidium bromide. The gel was first run at 8 V/cm for 3 min until the DNA moved out of the loading gel, after which the voltage was lowered to 4 V/cm. The duration of electrophoresis was adjusted according to specific conditions. Last, DNA bands visualized using a gel imaging analysis system. 
Judgment of results
Three independent PCR amplification verifications were performed. If target gene was not amplified, deletion at the site was confirmed.
Statistical analysis
Experimental data were processed using the SPSS 19.0 software. Comparisons between groups were performed using the Student's t-test. Enumeration data were processed by χ 2 tests. P < 0.05 was denoted as statistically significant. 
RESULTS
PCR amplification products
Y chromosome microdeletion
In all 50 healthy males, no microdeletion was observed at AZF on the Y chromosome. As expected, DNA from the healthy female controls did not show electrophoretic bands. We found that 28 out of the 166 infertile males (16.9%), 16 out of the 90 oligospermia patients (17.8%), and 12 out of the 76 azoospermia (15.8%) patients had Y chromosome AZF microdeletion. We did not detect any differences in the incidence of Y chromosome microdeletion between patient groups. However, a significant difference in Y chromosome microdeletion frequency was observed between the healthy control group and the infertile male group (P < 0.01).
The distribution of the different types of AZF microdeletion was as follows: 6 cases of AZFa (21.40%), 3 cases of AZFb (10.70%), 15 cases of AZFc (53.60%), 4 cases of AZFd (14.30%), 3 cases of AZFa + AZFc (10.70%), 4 cases of AZFb + AZFc (14.30%), 2 cases of AZFc + AZFd (7.10%), and 1 case of AZFb + AZFc + AZFd (3.60%). The incidence of AZFc microdeletion was the highest, followed by AZFb + AZFc, AZfa + AZFc, AZFb, AZFc + AZFd, and AZFb + AZFc + AZFd. Statistical analysis indicated that the incidence of AZFc microdeletions was much higher as compared to that of AZFb microdeletions (P < 0.05). Details are shown in Table 2 . 
DISCUSSION
A recent research (Benoff et al., 2004) suggests that genetic causes of male infertility include Y chromosome microdeletion, genetic mutation, and single nucleotide polymorphism, as well as chromosomal aberration. Among these, AZF microdeletion is a commonly observed genetic cause that is secondary to Klinefelter syndrome. Shimizu et al. (2002) proposed that approximately 10% of non-obstructive azoospermia patients are positive for Y chromosome AZF microdeletion. Similarly, Ristanovic et al. (2007) observed high incidence of AZFc microdeletion among patients suffering from severe oligospermia in Serbia. Therefore, extensive research has been conducted on azoospermia and severe oligospermia induced by Y chromosome microdeletions
The incidence of Y chromosome deletion is 10.8% among Chinese infertile males, and its incidence among azoospermia and severe oligospermia patients is 11.75 and 8.51%, respectively (Arruda et al., 2007; Li et al., 2015) . The AZF site, located on the long arm of the Y chromosome, contains a large number of microdeletions. AZF microdeletions can result in various spermatogenic disorders and thus induce infertility. There are four sub-areas in AZF: AZFa, AZFb, AZFc, and AZFd; microdeletion in different areas can lead to different clinical outcomes (Jiang et al., 1999; Dada et al., 2011) . AZFa microdeletions generally lead to azoospermia and small testicular volume; AZFb microdeletions result in termination of sperm production; AZFc microdeletions can produce a small quantity of active sperms and a large number of abnormal sperms; and AZFd microdeletions leads to mild oligospermia, where a normal number of sperms is produced, but the sperms show abnormal form. Several studies (Chiang et al., 2000; Dohle et al., 2002) have found that 60% of Y chromosome microdeletions occur in AFCs. The results obtained in the current study suggest that 15 out of 28 cases of AZF microdeletions were AZFc microdeletions, (53.60%), which is consistent with previous findings (Chiang et al., 2000; Dohle et al., 2002) .
With the development of sperm acquisition technology and ICSI, some AZFc microdeletion patients can recover and successfully fertilize their female partners via ICSI. Choi et al. (2013) previously performed testicular needle aspirations on 21 azoospermia patients who had AZFc microdeletions. The sperms that satisfied the quality standard for ICSI were successively acquired from 8 patients (38%). AZF may be passed onto the next male generation; hence, it is beneficial to label specific DNA sequences on the Y chromosome, perform PCR screening for patients with severe oligospermia and azoospermia, perform preimplantation genetic diagnosis for patients with microdeletion, and ensure that sperms are only implanted into female embryos (Foresta et al., 2001) . Additionally, determination of spermatogenetic failures at the molecular level can avoid unnecessary treatments, which can reduce economic burden and pain for patients.
In this study, 166 infertile males underwent Y chromosome microdeletion analysis. Twenty-eight patients had Y chromosome microdeletions (16.90%): 16 of the 90 cases of severe oligospermia and 12 of the 76 cases of non-obstructive azoospermia. No significant difference in the rate of incidence was detected between these two groups. Among the 28 cases of Y chromosome microdeletion, different types of microdeletions were observed; these included AZFb microdeletions, AZFc microdeletions, AZFa + AZFc microdeletions, AZFc + AZFd microdeletions, and AZFb + AZFc + AZFd microdeletion. AZFc microdeletion had the highest incidence rate. The incidence rates of AZF microdeletions in patients with severe oligospermia and azoospermia were similar.
This study has shown that Y chromosome microdeletion is a major genetic cause of primary male infertility. Detection of Y chromosome microdeletions is of great use for guiding clinical diagnosis, helping selecting treatment schemes, and reducing the incidence of this genetic disease. Therefore, Y chromosome microdeletion examinations are needed before formulation of the treatment protocol for infertile patients with abnormal sperms.
In this study, the sample size and the number of genetic loci were limited. To better understand the pathogenesis of male infertility, studies with larger sample sizes and more genetic loci need to be carried out.
